Literature DB >> 871734

Prognosis of Henoch-Schönlein nephritis in children.

R Counahan, M H Winterborn, R H White, J M Heaton, S R Meadow, N H Bluett, H Swetschin, J S Cameron, C Chantler.   

Abstract

All the survivors of a series of 88 patients with Henoch-Schönlein nephritis were examined after a follow-up of six and a half to 21 years (mean 9-9). Sixty-one patients had no demonstrable abnormality; six had minor urinary abnormalities; five had hypertension without urinary abnormally or renal dysfunction; four had heavy proteinuria; eight were in chronic renal failure, three of whom were on regular dialysis; and four patients had died within 25 months of onset. Neither corticosteroids nor immunosuppressive drugs alone or in combination appeared to influence the outcome. A clinical presentation with a combination of acute nephritis and a nephrotic syndrome and a high proportion of crescents in renal biopsy specimens was associated with a poor outcome. Neither the clinical presentation nor the renal morphology were, however, precise determinants of outcome. Outcome was not related to age, associated streptococcal infection, or recurrences of the rash. The clinical state two years after presentation was compared with the state six and a half years or more after presentation in 76 patients. The clinical state had changed in 32 patients, in 17 of whom it had deteriorated. It was not possible to identify with any certainty the patients who would deteriorate (or improve). Patients who have had Henoch-Schönlein nephritis should be followed up for at least five years.

Entities:  

Mesh:

Year:  1977        PMID: 871734      PMCID: PMC1631306          DOI: 10.1136/bmj.2.6078.11

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.

Authors:  C B Brown; D Wilson; D Turner; J S Cameron; C S Ogg; C Chantler; D Gill
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

2.  Anticoagulants in "irreversible" acute renal failure.

Authors:  P Kincaid-Smith; B M Saker; K F Fairley
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

3.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

4.  Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid.

Authors:  C Chantler; T M Barratt
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

  4 in total
  95 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

3.  Cyclosporin A therapy for Henoch-Schönlein nephritis with nephrotic-range proteinuria.

Authors:  Jee Min Park; Sung Chul Won; Jae Il Shin; Hyunee Yim; Ki Soo Pai
Journal:  Pediatr Nephrol       Date:  2010-12-24       Impact factor: 3.714

4.  Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population.

Authors:  M Stewart; J M Savage; B Bell; B McCord
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

5.  Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children.

Authors:  J I Shin; J M Park; Y H Shin; J S Lee; H J Jeong
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

6.  Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Örmälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2012-02-05       Impact factor: 3.714

7.  Henoch-Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome.

Authors:  Daimei Sasayama; Yasuhiro Shimojima; Takahisa Gono; Kazuma Kaneko; Masayuki Matsuda; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 2.980

8.  Asymptomatic haematuria and proteinuria: renal pathology and clinical outcome in 54 children.

Authors:  S Hisano; K Ueda
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 9.  Clinical practice: Diagnosis and management of Henoch-Schönlein purpura.

Authors:  Hugh J McCarthy; E Jane Tizard
Journal:  Eur J Pediatr       Date:  2009-12-12       Impact factor: 3.183

10.  Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.

Authors:  Hui Xu; Guizhen Jiang; Hongqiang Shen; Wei Li; Jianhua Mao; Yanxiang Pan
Journal:  Rheumatol Int       Date:  2017-09-13       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.